Silent HIV infection

Fernando Aiuti, Fabrizio Ensoli, Valeria Fiorelli, Ivano Mezzaroma, Elena Pinter, Emma Guerra, Anna Rita Varani

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The period of latency between infection by the human immunodeficiency virus type-1 (HIV-1) and the production of specific antibodies to viral antigens may be prolonged and, occasionally, may last for years. This condition of seronegative infection could represent a serious risk of viral transmission from subjects who are unaware of their status. However, whether these individuals are actually infectious, especially through body fluids, has not been clarified. We have performed a prospective study in 65 high-risk individuals seronegative for HIV-1 antibodies for a prolonged period of time. Twelve of them (18%) were shown to be carriers of HIV-1 proviral sequences by the polymerase chain reaction (PCR). The virus was isolated from mitogen-stimulated peripheral blood lymphocytes in five out of ten subjects tested since the first positive PCR. In two of them, virus could also be isolated from cell-free plasma, subsequently they remained seronegative during 10 months of follow-up. These data indicate that delayed seroconversions may be associated with productive infection, suggesting that mechanism(s) other than viral latency may be responsible for the absence of antibody responses to HIV-1 proteins. Furthermore, our findings suggest that prolonged seronegative individuals can transmit HIV infection through their body fluids.

Original languageEnglish
Pages (from-to)538-541
Number of pages4
JournalVaccine
Volume11
Issue number5
DOIs
Publication statusPublished - 1993

Fingerprint

HIV infections
Human immunodeficiency virus 1
HIV Infections
HIV-1
body fluids
Body Fluids
antibodies
Antibody Formation
Infection
polymerase chain reaction
infection
Virus Latency
Viruses
Human Immunodeficiency Virus Proteins
Polymerase Chain Reaction
viruses
Viral Antigens
viral antigens
seroconversion
Plasma Cells

Keywords

  • HIV
  • polymerase chain reaction
  • prospective study
  • silent infection

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Aiuti, F., Ensoli, F., Fiorelli, V., Mezzaroma, I., Pinter, E., Guerra, E., & Varani, A. R. (1993). Silent HIV infection. Vaccine, 11(5), 538-541. https://doi.org/10.1016/0264-410X(93)90226-N

Silent HIV infection. / Aiuti, Fernando; Ensoli, Fabrizio; Fiorelli, Valeria; Mezzaroma, Ivano; Pinter, Elena; Guerra, Emma; Varani, Anna Rita.

In: Vaccine, Vol. 11, No. 5, 1993, p. 538-541.

Research output: Contribution to journalArticle

Aiuti, F, Ensoli, F, Fiorelli, V, Mezzaroma, I, Pinter, E, Guerra, E & Varani, AR 1993, 'Silent HIV infection', Vaccine, vol. 11, no. 5, pp. 538-541. https://doi.org/10.1016/0264-410X(93)90226-N
Aiuti F, Ensoli F, Fiorelli V, Mezzaroma I, Pinter E, Guerra E et al. Silent HIV infection. Vaccine. 1993;11(5):538-541. https://doi.org/10.1016/0264-410X(93)90226-N
Aiuti, Fernando ; Ensoli, Fabrizio ; Fiorelli, Valeria ; Mezzaroma, Ivano ; Pinter, Elena ; Guerra, Emma ; Varani, Anna Rita. / Silent HIV infection. In: Vaccine. 1993 ; Vol. 11, No. 5. pp. 538-541.
@article{98cbc9fc2f924de9a866f3e233d8199b,
title = "Silent HIV infection",
abstract = "The period of latency between infection by the human immunodeficiency virus type-1 (HIV-1) and the production of specific antibodies to viral antigens may be prolonged and, occasionally, may last for years. This condition of seronegative infection could represent a serious risk of viral transmission from subjects who are unaware of their status. However, whether these individuals are actually infectious, especially through body fluids, has not been clarified. We have performed a prospective study in 65 high-risk individuals seronegative for HIV-1 antibodies for a prolonged period of time. Twelve of them (18{\%}) were shown to be carriers of HIV-1 proviral sequences by the polymerase chain reaction (PCR). The virus was isolated from mitogen-stimulated peripheral blood lymphocytes in five out of ten subjects tested since the first positive PCR. In two of them, virus could also be isolated from cell-free plasma, subsequently they remained seronegative during 10 months of follow-up. These data indicate that delayed seroconversions may be associated with productive infection, suggesting that mechanism(s) other than viral latency may be responsible for the absence of antibody responses to HIV-1 proteins. Furthermore, our findings suggest that prolonged seronegative individuals can transmit HIV infection through their body fluids.",
keywords = "HIV, polymerase chain reaction, prospective study, silent infection",
author = "Fernando Aiuti and Fabrizio Ensoli and Valeria Fiorelli and Ivano Mezzaroma and Elena Pinter and Emma Guerra and Varani, {Anna Rita}",
year = "1993",
doi = "10.1016/0264-410X(93)90226-N",
language = "English",
volume = "11",
pages = "538--541",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Silent HIV infection

AU - Aiuti, Fernando

AU - Ensoli, Fabrizio

AU - Fiorelli, Valeria

AU - Mezzaroma, Ivano

AU - Pinter, Elena

AU - Guerra, Emma

AU - Varani, Anna Rita

PY - 1993

Y1 - 1993

N2 - The period of latency between infection by the human immunodeficiency virus type-1 (HIV-1) and the production of specific antibodies to viral antigens may be prolonged and, occasionally, may last for years. This condition of seronegative infection could represent a serious risk of viral transmission from subjects who are unaware of their status. However, whether these individuals are actually infectious, especially through body fluids, has not been clarified. We have performed a prospective study in 65 high-risk individuals seronegative for HIV-1 antibodies for a prolonged period of time. Twelve of them (18%) were shown to be carriers of HIV-1 proviral sequences by the polymerase chain reaction (PCR). The virus was isolated from mitogen-stimulated peripheral blood lymphocytes in five out of ten subjects tested since the first positive PCR. In two of them, virus could also be isolated from cell-free plasma, subsequently they remained seronegative during 10 months of follow-up. These data indicate that delayed seroconversions may be associated with productive infection, suggesting that mechanism(s) other than viral latency may be responsible for the absence of antibody responses to HIV-1 proteins. Furthermore, our findings suggest that prolonged seronegative individuals can transmit HIV infection through their body fluids.

AB - The period of latency between infection by the human immunodeficiency virus type-1 (HIV-1) and the production of specific antibodies to viral antigens may be prolonged and, occasionally, may last for years. This condition of seronegative infection could represent a serious risk of viral transmission from subjects who are unaware of their status. However, whether these individuals are actually infectious, especially through body fluids, has not been clarified. We have performed a prospective study in 65 high-risk individuals seronegative for HIV-1 antibodies for a prolonged period of time. Twelve of them (18%) were shown to be carriers of HIV-1 proviral sequences by the polymerase chain reaction (PCR). The virus was isolated from mitogen-stimulated peripheral blood lymphocytes in five out of ten subjects tested since the first positive PCR. In two of them, virus could also be isolated from cell-free plasma, subsequently they remained seronegative during 10 months of follow-up. These data indicate that delayed seroconversions may be associated with productive infection, suggesting that mechanism(s) other than viral latency may be responsible for the absence of antibody responses to HIV-1 proteins. Furthermore, our findings suggest that prolonged seronegative individuals can transmit HIV infection through their body fluids.

KW - HIV

KW - polymerase chain reaction

KW - prospective study

KW - silent infection

UR - http://www.scopus.com/inward/record.url?scp=0027253745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027253745&partnerID=8YFLogxK

U2 - 10.1016/0264-410X(93)90226-N

DO - 10.1016/0264-410X(93)90226-N

M3 - Article

C2 - 8488706

AN - SCOPUS:0027253745

VL - 11

SP - 538

EP - 541

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 5

ER -